US Broker Ratings

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 75% Potential Upside in the Biotechnology Sector

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has been on the radar of investors and analysts alike, given its significant role in developing mRNA-based medicines. As..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking a 28.33% Potential Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the competitive biotechnology sector, offering a compelling investment narrative with its innovative approach to drug delivery and a promising 28.33% potential upside..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Current Valuations Amid Growth Challenges

Henry Schein, Inc. (HSIC), a prominent player in the healthcare sector, is a leading distributor of healthcare products and services, primarily catering to office-based dental and medical practitioners across the..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth with a 42% Revenue Surge Amidst Mixed Analyst Ratings

Oscar Health, Inc. (NYSE: OSCR), a pioneering healthcare technology firm, is making waves in the healthcare plans sector with its robust revenue growth. Investors are keenly evaluating the company’s trajectory..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 15% Potential Upside

Bausch + Lomb Corporation (BLCO), a prominent player in the healthcare sector, is renowned for its strong presence in the medical instruments and supplies industry. With a global footprint spanning..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 27.83% Potential Upside with Solid Revenue Growth

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, stands as a compelling investment opportunity with a market capitalization of $11.48 billion. Based in King of..

Avidity Biosciences, Inc. (RNA) Investor Outlook: Navigating the 131% Upside Potential

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with a potential upside of 131.61%, making it a compelling candidate in the biotechnology sector. Headquartered in San Diego,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a Robust 47.75% Potential Upside for Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a cutting-edge player in the biotechnology sector, is capturing investor attention with its impressive trajectory in genetic medicines. Based in Pittsburgh, Pennsylvania, the company focuses..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech Contender with a Promising 286% Upside

Vaxcyte, Inc. (PCVX), a clinical-stage biotech company based in San Carlos, California, is setting the stage for significant market interest with a robust pipeline focused on innovative vaccine solutions for..

Alkermes plc (ALKS) Stock Analysis: Potential 42% Upside Amidst Strategic Developments

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, stands at the forefront of the biopharmaceutical industry, specifically within the specialties of drug manufacturing for both generic and proprietary products. With..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 62% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA) presents an intriguing opportunity for investors seeking exposure in the biotechnology sector. With a market capitalization of $4.34 billion, this U.S.-based company is making waves..

GSK plc (GSK) Stock Analysis: Exploring a 7.66% Upside Potential for Investors

GSK plc (NYSE: GSK), a titan in the healthcare sector, continues to draw attention from investors with its robust market presence and promising growth prospects. With a market capitalization of..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating the Biotech Growth with a 55.5% Revenue Surge

As the biotechnology sector continues to evolve, Blueprint Medicines Corporation (NASDAQ: BPMC) stands out with its innovative approach to precision therapies for genomically defined cancers and blood disorders. With a..

Elanco Animal Health (ELAN) Stock Analysis: Exploring Growth Potential with a 4% Upside

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the niche of drug manufacturers focusing on both specialty and generic products. With..

Tenet Healthcare Corporation (THC) Stock Analysis: Evaluating the 7.60% Potential Upside

Investors eyeing Tenet Healthcare Corporation (NYSE: THC) may find compelling opportunities as the company positions itself within the dynamic healthcare sector. With a market cap of $16.13 billion, Tenet stands..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 28.84% Potential Upside Amid Mixed Financial Signals

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the medical devices industry, offers a complex investment landscape as it navigates through mixed financial signals. With a market capitalization of..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 9.39% Potential Upside in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a compelling player in the healthcare sector, particularly within the niche of over-the-counter (OTC) health and personal care products. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Riding the Wave of 30.60% Revenue Growth in the Biotechnology Sphere

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology industry with its robust focus on oncology, seeking to address some of the most challenging cancers. With a market capitalization of..

Charles River Laboratories (CRL) Stock Analysis: Navigating Healthcare’s Dynamic Landscape with a 4.09% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a stalwart in the healthcare sector’s diagnostics and research industry, presents an intriguing case for investors navigating the current market landscape. With its..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 30.51% Potential Upside

Teleflex Incorporated (NYSE: TFX), a leader in medical instruments and supplies, presents a compelling investment case within the healthcare sector. As a company that has been pioneering in the design..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds